$85M Default Risk Keeps K-V Pharma Ch. 11 Plan On Schedule
A New York bankruptcy judge on Wednesday refused to extend the timeline for K-V Pharmaceutical Co.'s reorganization plan, saying that prolonging the process would unnecessarily risk K-V's default of an outstanding...To view the full article, register now.
Already a subscriber? Click here to view full article